SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/23 Cryoport, Inc. 10-K 12/31/22 119:18M Toppan Merrill/FA2 |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 3.97M 2: EX-21 Subsidiaries List HTML 37K 3: EX-23.1 Consent of Expert or Counsel HTML 34K 4: EX-31.1 Certification -- §302 - SOA'02 HTML 37K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 37K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 33K 7: EX-32.2 Certification -- §906 - SOA'02 HTML 33K 13: R1 Document and Entity Information HTML 100K 14: R2 Consolidated Balance Sheets HTML 154K 15: R3 Consolidated Balance Sheets (Parenthetical) HTML 62K 16: R4 Consolidated Statements of Operations HTML 131K 17: R5 Consolidated Statements of Comprehensive Loss HTML 61K 18: R6 Consolidated Statements of Stockholders' Equity HTML 154K 19: R7 Consolidated Statements of Stockholders' Equity HTML 37K (Parenthetical) 20: R8 Consolidated Statements of Cash Flows HTML 174K 21: R9 Nature of the Business HTML 36K 22: R10 Summary of Significant Accounting Policies HTML 165K 23: R11 Acquisitions HTML 138K 24: R12 Cash, Cash Equivalents and Short-Term Investments HTML 160K 25: R13 Fair Value Measurements HTML 156K 26: R14 Inventory HTML 44K 27: R15 Property and Equipment HTML 71K 28: R16 Goodwill and Intangible Assets HTML 141K 29: R17 Accrued Compensation and Related Expenses HTML 44K 30: R18 Convertible Senior Notes HTML 88K 31: R19 Notes Payable HTML 69K 32: R20 Leases HTML 122K 33: R21 Employee Benefit Plans HTML 39K 34: R22 Commitments and Contingencies HTML 41K 35: R23 Stockholders' Equity HTML 65K 36: R24 Stock-Based Compensation HTML 220K 37: R25 Income Taxes HTML 190K 38: R26 Quarterly Financial Data HTML 99K 39: R27 Summary of Significant Accounting Policies HTML 241K (Policies) 40: R28 Summary of Significant Accounting Policies HTML 105K (Tables) 41: R29 Acquisitions (Tables) HTML 128K 42: R30 Cash, Cash Equivalents and Short-Term Investments HTML 164K (Tables) 43: R31 Fair Value Measurements (Tables) HTML 154K 44: R32 Inventory (Tables) HTML 45K 45: R33 Property and Equipment (Tables) HTML 72K 46: R34 Goodwill and Intangible Assets (Tables) HTML 148K 47: R35 Accrued Compensation and Related Expenses (Tables) HTML 43K 48: R36 Convertible Senior Notes (Tables) HTML 61K 49: R37 Notes Payable (Tables) HTML 71K 50: R38 Leases (Tables) HTML 125K 51: R39 Stockholders' Equity (Tables) HTML 39K 52: R40 Stock-Based Compensation (Tables) HTML 226K 53: R41 Income Taxes (Tables) HTML 190K 54: R42 Quarterly Financial Data (Tables) HTML 98K 55: R43 Summary of Significant Accounting Policies - HTML 55K Disaggregates Our Revenues by Major Source (Details) 56: R44 Summary of Significant Accounting Policies - HTML 52K Disaggregation Our Geographical Revenues by Origin (Details) 57: R45 Summary of Significant Accounting Policies - Basic HTML 75K and Diluted Net Loss Per Share (Details) 58: R46 Summary of Significant Accounting Policies - HTML 44K Antidilutive shares (Details) 59: R47 Summary of Significant Accounting Policies - HTML 170K Additional information (Details) 60: R48 Acquisition - Additional information (Details) HTML 115K 61: R49 Acquisitions - Allocation of purchase price HTML 104K (Details) 62: R50 Acquisition - Preliminary Fair Value of Intangible HTML 76K Assets (Details) 63: R51 Cash, Cash Equivalents and Short-Term Investments HTML 58K (Details) 64: R52 Cash, Cash Equivalents and Short-Term Investments HTML 44K - Available-for-sale Investments (Details) 65: R53 Cash, Cash Equivalents and Short-term Investments HTML 52K - Contractual Maturities (Details) 66: R54 Cash, Cash Equivalents and Short-Term Investments HTML 57K - Company's gross unrealized losses and fair value (Details) 67: R55 Cash, Cash Equivalents and Short-Term Investments HTML 41K - Equity Investments (Details) 68: R56 Fair Value Measurements - Fair value hierarchy HTML 64K (Details) 69: R57 Fair Value Measurements - Estimated fair values HTML 40K and the carrying values (Details) 70: R58 Fair Value Measurements - losses recognized in HTML 50K earnings and the change in net asset - (Details) 71: R59 Fair Value Measurements - Additional Information HTML 38K (Details) 72: R60 Inventory (Details) HTML 39K 73: R61 Property and Equipment (Details) HTML 59K 74: R62 Property and Equipment - Geographic information HTML 38K (Details) 75: R63 Property and Equipment - Additional information HTML 38K (Details) 76: R64 Goodwill and Intangible Assets - Schedule of HTML 51K goodwill (Details) 77: R65 Goodwill and Intangible Assets - Intangible Assets HTML 66K (Details) 78: R66 Goodwill and Intangible Assets - Expected future HTML 46K amortization (Details) 79: R67 Goodwill and Intangible Assets - Additional HTML 34K Information (Details) 80: R68 Accrued Compensation and Related Expenses HTML 38K (Details) 81: R69 Convertible Senior Notes - Components of HTML 43K Convertible notes payable (Details) 82: R70 Convertible Senior Notes - Interest expenses HTML 40K incurred on Convertible notes payable (Details) 83: R71 Convertible Senior Notes - Additional information HTML 118K (Details) 84: R72 Notes Payable (Details) HTML 53K 85: R73 Notes Payable - Interest expense (Details) HTML 43K 86: R74 Notes Payable - Future note payments (Details) HTML 52K 87: R75 Note Payable - Additional information (Details) HTML 54K 88: R76 Leases - Components Of Lease Cost (Details) HTML 44K 89: R77 Leases - Supplemental Cash Flows Information HTML 58K (Details) 90: R78 Leases - Future Payments Under Non-Cancellable HTML 74K Leases (Details) 91: R79 Leases - Additional Information (Details) HTML 44K 92: R80 Employee Benefit Plans (Details) HTML 46K 93: R81 Commitments and Contingencies (Details) HTML 38K 94: R82 Stockholders' Equity - Authorized Stock (Details) HTML 50K 95: R83 Stockholders' Equity - Common Stock Issuances For HTML 39K Services (Details) 96: R84 Stockholders' Equity - Repurchase Program HTML 40K (Details) 97: R85 Stockholders' Equity - November 2021 Registered HTML 49K Direct Placement and Stock Purchase Agreements (Details) 98: R86 Stockholders' Equity - January 2021 Public HTML 42K Offering (Details) 99: R87 Stockholders' Equity - Blackstone Private HTML 115K Placement and Conversion (Details) 100: R88 Stockholders' Equity - Common Stock Reserved for HTML 47K Future Issuance (Details) 101: R89 Stock-Based Compensation - Assumptions Used to HTML 49K Estimate Fair Value of Stock Options (Details) 102: R90 Stock-Based Compensation - Stock-based HTML 40K Compensation Expense (Details) 103: R91 Stock-Based Compensation - Stock Option Activity HTML 101K (Details) 104: R92 Stock-Based Compensation - Schedule of Stock HTML 83K Options Outstanding and Exercisable (Details) 105: R93 Stock-Based Compensation - Restricted stock unit HTML 55K (Details) 106: R94 Stock-Based Compensation - Additional Information HTML 74K (Details) 107: R95 Income Taxes - Loss Before Provision For Income HTML 38K Taxes (Details) 108: R96 Income Taxes - Expense For Income Taxes (Details) HTML 61K 109: R97 Income Taxes - Schedule of Deferred Tax Assets HTML 72K (Details) 110: R98 Income Taxes - net deferred tax liability as HTML 39K presented in consolidated balance sheet (Details) 111: R99 Income Taxes - Schedule of Income Tax Provision HTML 63K (Details) 112: R100 Income Taxes - Schedule of unrecognized tax HTML 41K positions (Details) 113: R101 Income Taxes - Additional information (Details) HTML 47K 114: R102 Quarterly Financial Data (Details) HTML 73K 117: XML IDEA XML File -- Filing Summary XML 224K 115: XML XBRL Instance -- cyrx-20221231x10k_htm XML 4.83M 116: EXCEL IDEA Workbook of Financial Reports XLSX 262K 9: EX-101.CAL XBRL Calculations -- cyrx-20221231_cal XML 315K 10: EX-101.DEF XBRL Definitions -- cyrx-20221231_def XML 1.05M 11: EX-101.LAB XBRL Labels -- cyrx-20221231_lab XML 2.26M 12: EX-101.PRE XBRL Presentations -- cyrx-20221231_pre XML 1.63M 8: EX-101.SCH XBRL Schema -- cyrx-20221231 XSD 287K 118: JSON XBRL Instance as JSON Data -- MetaLinks 667± 1.08M 119: ZIP XBRL Zipped Folder -- 0001410578-23-000188-xbrl Zip 989K
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) |
| Registration Statement (Form S-3 No. 333-230237, 333-229395, and 333-251354) of Cryoport, Inc.; |
| ||
(2) |
| Registration Statement (Form S-8 No. 333-225387 and 333-257368) pertaining to the 2018 Omnibus Equity Incentive Plan; |
| ||
(3) |
| Registration Statement (Form S-8 No. 333-208381) pertaining to the 2015 Omnibus Equity Incentive Plan; |
| | |
(4) |
| Registration Statement (Form S-8 No. 333-177168, 333-184543, and 333-197437) pertaining to the 2011 Stock Incentive Plan; |
of our reports dated February 28, 2023, with respect to the consolidated financial statements of Cryoport, Inc. and the effectiveness of internal control over financial reporting of Cryoport, Inc. included in this Annual Report (Form 10-K) of Cryoport, Inc. for the year ended December 31, 2022.
Irvine, California
February 28, 2023
Guidance:
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/28/23 | None on these Dates | ||
For Period end: | 12/31/22 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/21/23 Cryoport, Inc. 424B3 1:533K Toppan Merrill/FA 12/15/23 Cryoport, Inc. POS AM 2:866K Toppan Merrill/FA 12/15/23 Cryoport, Inc. POSASR 12/15/23 6:967K Toppan Merrill/FA |